Clinical trial
PARTNER 3 Trial - SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Mitral Bioprosthetic Valve
NCT03193801 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PARTNER 3 Trial - SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Mitral Bioprosthetic Valve
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 1, 2018
- Completion date
- August 31, 2031
- Enrollment
- 53 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, mitral valve disease, mitral valve insufficiency, mitral valve regurgitation